These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 36209251)
21. The Effect of Patient Education and Telemedicine Reminders on Adherence to Eye Drops for Glaucoma. Lai Y; Wu Y; Chai C; Yen CC; Ho Y; Eng TC; Jain P; Koh V Ophthalmol Glaucoma; 2020; 3(5):369-376. PubMed ID: 32980041 [TBL] [Abstract][Full Text] [Related]
22. Feasibility, Patient Acceptability, and Preliminary Efficacy of a Culturally Informed, Health Promotion Program to Improve Glaucoma Medication Adherence Among African Americans: "Glaucoma Management Optimism for African Americans Living with Glaucoma" (GOAL). Dreer LE; Owsley C; Campbell L; Gao L; Wood A; Girkin CA Curr Eye Res; 2016; 41(1):50-8. PubMed ID: 25625187 [TBL] [Abstract][Full Text] [Related]
23. Treatment patterns and medication adherence of patients with glaucoma in South Korea. Kim CY; Park KH; Ahn J; Ahn MD; Cha SC; Kim HS; Kim JM; Kim MJ; Kim TW; Kim YY; Lee JW; Park SW; Sohn YH; Sung KR; Yoo C; Cha J; Kim YJ Br J Ophthalmol; 2017 Jun; 101(6):801-807. PubMed ID: 28270490 [TBL] [Abstract][Full Text] [Related]
24. Drug adherence for antihypertensive medications and its determinants among adult hypertensive patients attending in chronic clinics of referral hospitals in Northwest Ethiopia. Mekonnen HS; Gebrie MH; Eyasu KH; Gelagay AA BMC Pharmacol Toxicol; 2017 Apr; 18(1):27. PubMed ID: 28381241 [TBL] [Abstract][Full Text] [Related]
25. Text Parsing-Based Identification of Patients with Poor Glaucoma Medication Adherence in the Electronic Health Record. Hamid MS; Valicevic A; Brenneman B; Niziol LM; Stein JD; Newman-Casey PA Am J Ophthalmol; 2021 Feb; 222():54-59. PubMed ID: 32926847 [TBL] [Abstract][Full Text] [Related]
26. How glaucoma patient characteristics, self-efficacy and patient-provider communication are associated with eye drop technique. Sayner R; Carpenter DM; Robin AL; Blalock SJ; Muir KW; Vitko M; Hartnett ME; Lawrence SD; Giangiacomo AL; Tudor G; Goldsmith JA; Sleath B Int J Pharm Pract; 2016 Apr; 24(2):78-85. PubMed ID: 26303667 [TBL] [Abstract][Full Text] [Related]
27. Patient Experience during the Support, Educate, Empower Glaucoma Coaching Program to Improve Medication Adherence: A Pilot Study. Hollenhorst CN; Elliott V; Heisler M; Schneider K; Resnicow K; Newman-Casey PA Ophthalmol Glaucoma; 2020; 3(4):238-252. PubMed ID: 33008556 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of self-reported early glaucoma eye drop bottle exhaustion and associated risk factors: a patient survey. Moore DB; Walton C; Moeller KL; Slabaugh MA; Mudumbai RC; Chen PP BMC Ophthalmol; 2014 Jun; 14():79. PubMed ID: 24927769 [TBL] [Abstract][Full Text] [Related]
29. Impact of a health communication intervention to improve glaucoma treatment adherence. Results of the interactive study to increase glaucoma adherence to treatment trial. Glanz K; Beck AD; Bundy L; Primo S; Lynn MJ; Cleveland J; Wold JA; Echt KV Arch Ophthalmol; 2012 Oct; 130(10):1252-8. PubMed ID: 22688429 [TBL] [Abstract][Full Text] [Related]
30. Validation of a short version of the glaucoma medication self-efficacy questionnaire. Sleath B; Blalock SJ; Stone JL; Skinner AC; Covert D; Muir K; Robin AL Br J Ophthalmol; 2012 Feb; 96(2):258-62. PubMed ID: 21610264 [TBL] [Abstract][Full Text] [Related]
31. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study. Boland MV; Chang DS; Frazier T; Plyler R; Friedman DS JAMA Ophthalmol; 2014 Jul; 132(7):838-44. PubMed ID: 24830878 [TBL] [Abstract][Full Text] [Related]
32. The Impact of the Support, Educate, Empower Personalized Glaucoma Coaching Pilot Study on Glaucoma Medication Adherence. Newman-Casey PA; Niziol LM; Lee PP; Musch DC; Resnicow K; Heisler M Ophthalmol Glaucoma; 2020; 3(4):228-237. PubMed ID: 33012330 [TBL] [Abstract][Full Text] [Related]
33. Inpatient Adherence to Topical Glaucoma Medications before and after an Educational Intervention. Mammo DA; Strampe M; Naravane A; Mallory PW; Boysen J; Wright MM Ophthalmol Glaucoma; 2020; 3(5):339-342. PubMed ID: 32980036 [TBL] [Abstract][Full Text] [Related]
34. Factors associated with adherence to glaucoma pharmacotherapy in the primary care setting. Cohen Castel O; Keinan-Boker L; Geyer O; Milman U; Karkabi K Fam Pract; 2014 Aug; 31(4):453-61. PubMed ID: 24927725 [TBL] [Abstract][Full Text] [Related]
35. Predicting Adherence With the Glaucoma Treatment Compliance Assessment Tool. Sanchez FG; Mansberger SL; Newman-Casey PA J Glaucoma; 2020 Nov; 29(11):1017-1024. PubMed ID: 32740508 [TBL] [Abstract][Full Text] [Related]
36. Adherence to Topical Medication in Patients with Inflammatory Eye Disease. Javidi H; Poonit N; Patel RP; Barry RJ; Rauz S; Murray PI Ocul Immunol Inflamm; 2021 Jul; 29(5):890-895. PubMed ID: 31944132 [No Abstract] [Full Text] [Related]
37. Review of glaucoma medication adherence monitoring in the digital health era. Erras A; Shahrvini B; Weinreb RN; Baxter SL Br J Ophthalmol; 2023 Feb; 107(2):153-159. PubMed ID: 33858837 [TBL] [Abstract][Full Text] [Related]
38. A nationwide survey of factors influencing adherence to ocular hypotensive eyedrops in Japan. Tsumura T; Kashiwagi K; Suzuki Y; Yoshikawa K; Suzumura H; Maeda T; Takeda R; Saito H; Araie M Int Ophthalmol; 2019 Feb; 39(2):375-383. PubMed ID: 29330811 [TBL] [Abstract][Full Text] [Related]
40. Real-world assessment of topical glaucoma medication persistence rates based on national pharmaceutical claim data in a defined population. Zhu Z; Jiang Y; Wang W; Scheetz J; Shang X; Zhang L; He M Clin Exp Ophthalmol; 2019 Sep; 47(7):881-891. PubMed ID: 31034700 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]